# ABCG1

## Overview
The ABCG1 gene encodes the ATP-binding cassette subfamily G member 1 (ABCG1) protein, which is a crucial component of the ATP-binding cassette (ABC) transporter family. This protein functions as a transmembrane transporter involved in the regulation of lipid homeostasis, particularly in the efflux of cholesterol and phospholipids to high-density lipoprotein (HDL) particles. ABCG1 is characterized by its six transmembrane domains and a single ATP-binding cassette, which are essential for its role in substrate transport across cellular membranes (Lorkowski2001Genomic). The protein operates as a half transporter, requiring dimerization to become functionally active, often forming homodimers or heterodimers with other ABC transporters such as ABCG4 (Hardy2017Critical). ABCG1 is predominantly expressed in macrophages, endothelial cells, and epithelial cells, and its activity is regulated by the liver-specific X receptor/retinoid X receptor (LXR/RXR) pathway, which is vital for lipid metabolism (Tarling2012Dancing; Lorkowski2001Genomic). The gene's expression and function are implicated in various physiological and pathological processes, including atherosclerosis and cancer, highlighting its significance in maintaining cellular lipid balance and influencing disease outcomes (Meng2021Diagnostic; Rozhkova2021Genomic).

## Structure
The ABCG1 protein is a member of the ATP-binding cassette (ABC) transporter family, specifically the subfamily G. It functions as a half transporter, requiring dimerization to form a functional unit. The protein contains six transmembrane domains and a single ATP-binding cassette, which includes conserved Walker A and B domains and a signature motif essential for ATP binding and hydrolysis, providing energy for substrate transport across membranes (Lorkowski2001Genomic).

The primary structure of ABCG1 consists of amino acid sequences that form these transmembrane and nucleotide-binding domains. The secondary structure likely includes alpha helices and beta sheets, typical of ABC transporters, although specific details are not provided in the context. The tertiary structure involves the folding of these elements into a functional transporter, while the quaternary structure involves the formation of homo- or heterodimers (Lorkowski2001Genomic).

The ABCG1 gene produces several splice variants, resulting in different isoforms with potentially distinct functions. These variants arise from alternative transcription start points and the presence of novel exons, leading to at least five different splice variants with various 5' ends (Lorkowski2001Genomic). The protein is predicted to localize primarily in the endoplasmic reticulum or plasma membrane (Lorkowski2001Genomic).

## Function
The ABCG1 gene encodes a protein that plays a critical role in lipid transport and homeostasis, particularly in the efflux of cholesterol and phospholipids from cells to high-density lipoprotein (HDL) particles. This process is essential for maintaining cellular lipid balance and preventing lipid accumulation, which can lead to atherosclerosis (Klucken2000ABCG1; Vaughan2005ABCG1). ABCG1 is primarily active in the plasma membrane and endoplasmic reticulum of cells, where it facilitates the redistribution of cholesterol to cell-surface domains accessible to HDL (Vaughan2005ABCG1).

ABCG1 functions as a half transporter that must dimerize to form an active transporter, often forming homodimers or heterodimers with ABCG4 (Hardy2017Critical). It is highly expressed in macrophages, endothelial cells, and epithelial cells, but not in hepatocytes or intestinal enterocytes (Tarling2012Dancing). The protein is regulated by the liver-specific X receptor/retinoid X receptor (LXR/RXR) pathway, which is crucial for lipid metabolism (Lorkowski2001Genomic). ABCG1's activity is dependent on a functional nucleotide-binding domain, which is necessary for its role in cholesterol redistribution and efflux (Vaughan2005ABCG1).

## Clinical Significance
Alterations in the expression of the ABCG1 gene are associated with several diseases, particularly those related to cholesterol metabolism and cardiovascular health. In atherosclerosis, ABCG1 expression is significantly reduced, leading to decreased cholesterol efflux and increased risk of the disease. This reduction is observed in patients with coronary artery disease (CAD) and myocardial infarction (MI), and is linked to genetic polymorphisms in the ABCG1 locus, such as g.-376C > T and g.-311T > A, which increase CAD risk (Rozhkova2021Genomic). 

MicroRNAs also play a role in modulating ABCG1 expression. For instance, miR-378 suppresses ABCG1, contributing to atherosclerosis progression by decreasing reverse cholesterol transport (RCT) in macrophages (Rozhkova2021Genomic). Similarly, miR-23a and miR-34a inhibit ABCG1 expression, promoting foam cell formation and plaque growth in atherosclerosis (Rozhkova2021Genomic).

In cancer, ABCG1 is implicated in clear cell renal cell carcinoma (ccRCC), where its overexpression is associated with longer overall survival, potentially due to its role in reducing cholesterol content in cancer cells (Meng2021Diagnostic). The gene's expression is also linked to the regulation of macrophage behavior, influencing tumor immunity and growth (Meng2021Diagnostic).

## Interactions
ABCG1 interacts with several proteins, playing a crucial role in cholesterol efflux and lipid homeostasis. One significant interaction is with caveolin-1 (CAV1), a protein that regulates ABCG1-mediated cholesterol efflux. This interaction is specific, as ABCG1 does not co-immunoprecipitate with flotillin-1 and -2. The binding site for CAV1 in ABCG1 is located in the largest putative intracellular loop and involves specific tyrosine residues. Mutations in this site impair the interaction and reduce cholesterol efflux, highlighting the importance of CAV1 in ABCG1 function (Gu2014Caveolin1).

ABCG1 also forms homodimers and can heterodimerize with ABCG4, another member of the ABC transporter family. These interactions have been demonstrated through co-immunoprecipitation experiments. The dimerization of ABCG1 is essential for its function, as inactive mutants can diminish the functional activity of the wild-type protein, indicating functional cooperativity between the dimer halves (Hegyi2016Functional).

Additionally, ABCG1 interacts with the adaptor protein Alix, which facilitates its interaction with the ubiquitin ligase NEDD4-1. This interaction is involved in cholesterol-sensitive regulation of ABCG1 levels, suggesting a role in cholesterol homeostasis (Alrosan2019The).


## References


[1. (Tarling2012Dancing) Elizabeth J. Tarling and Peter A. Edwards. Dancing with the sterols: critical roles for abcg1, abca1, mirnas, and nuclear and cell surface receptors in controlling cellular sterol homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1821(3):386–395, March 2012. URL: http://dx.doi.org/10.1016/j.bbalip.2011.07.011, doi:10.1016/j.bbalip.2011.07.011. This article has 64 citations.](https://doi.org/10.1016/j.bbalip.2011.07.011)

[2. (Klucken2000ABCG1) Jochen Klucken, Christa Büchler, Evelyn Orsó, Wolfgang E. Kaminski, Mustafa Porsch-Özcürümez, Gerhard Liebisch, Michael Kapinsky, Wendy Diederich, Wolfgang Drobnik, Michael Dean, Rando Allikmets, and Gerd Schmitz. Abcg1 (abc8), the human homolog of the drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proceedings of the National Academy of Sciences, 97(2):817–822, January 2000. URL: http://dx.doi.org/10.1073/pnas.97.2.817, doi:10.1073/pnas.97.2.817. This article has 446 citations.](https://doi.org/10.1073/pnas.97.2.817)

[3. (Hardy2017Critical) Lise Hardy, Eric Frisdal, and Wilfried Le Goff. Critical role of the human atp-binding cassette g1 transporter in cardiometabolic diseases. International Journal of Molecular Sciences, 18(9):1892, September 2017. URL: http://dx.doi.org/10.3390/ijms18091892, doi:10.3390/ijms18091892. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18091892)

[4. (Gu2014Caveolin1) Hong-mei Gu, Fa-qi Wang, and Da-wei Zhang. Caveolin-1 interacts with atp binding cassette transporter g1 (abcg1) and regulates abcg1-mediated cholesterol efflux. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1841(6):847–858, June 2014. URL: http://dx.doi.org/10.1016/j.bbalip.2014.02.002, doi:10.1016/j.bbalip.2014.02.002. This article has 28 citations.](https://doi.org/10.1016/j.bbalip.2014.02.002)

[5. (Meng2021Diagnostic) Fucheng Meng, Yafei Xiao, Longxiang Xie, Qiao Liu, and Keli Qian. Diagnostic and prognostic value of abc transporter family member abcg1 gene in clear cell renal cell carcinoma. Channels, 15(1):375–385, January 2021. URL: http://dx.doi.org/10.1080/19336950.2021.1909301, doi:10.1080/19336950.2021.1909301. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/19336950.2021.1909301)

[6. (Hegyi2016Functional) Zoltán Hegyi and László Homolya. Functional cooperativity between abcg4 and abcg1 isoforms. PLOS ONE, 11(5):e0156516, May 2016. URL: http://dx.doi.org/10.1371/journal.pone.0156516, doi:10.1371/journal.pone.0156516. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0156516)

[7. (Vaughan2005ABCG1) Ashley M. Vaughan and John F. Oram. Abcg1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. Journal of Biological Chemistry, 280(34):30150–30157, August 2005. URL: http://dx.doi.org/10.1074/jbc.m505368200, doi:10.1074/jbc.m505368200. This article has 222 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m505368200)

[8. (Alrosan2019The) Amjad Alrosan, Shereen M. Aleidi, Alryel Yang, Andrew J. Brown, and Ingrid C. Gelissen. The adaptor protein alix is involved in the interaction between the ubiquitin ligase nedd4-1 and its targets, abcg1 and abcg4. International Journal of Molecular Sciences, 20(11):2714, June 2019. URL: http://dx.doi.org/10.3390/ijms20112714, doi:10.3390/ijms20112714. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112714)

[9. (Rozhkova2021Genomic) Alexandra V. Rozhkova, Veronika G. Dmitrieva, Elena V. Nosova, Alexander D. Dergunov, Svetlana A. Limborska, and Liudmila V. Dergunova. Genomic variants and multilevel regulation of abca1, abcg1, and scarb1 expression in atherogenesis. Journal of Cardiovascular Development and Disease, 8(12):170, December 2021. URL: http://dx.doi.org/10.3390/jcdd8120170, doi:10.3390/jcdd8120170. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jcdd8120170)

[10. (Lorkowski2001Genomic) Stefan Lorkowski, Stephan Rust, Thomas Engel, Elisabeth Jung, Karin Tegelkamp, Erwin Arno Galinski, Gerd Assmann, and Paul Cullen. Genomic sequence and structure of the human abcg1 (abc8) gene. Biochemical and Biophysical Research Communications, 280(1):121–131, January 2001. URL: http://dx.doi.org/10.1006/BBRC.2000.4089, doi:10.1006/bbrc.2000.4089. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/BBRC.2000.4089)